Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -44.81%18.61M | ---- | -12.14%33.72M | ---- | -21.06%38.37M | ---- | -14.78%48.61M | ---- | 15.50%57.04M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -20.31%-1.85M | ---- | -209.05%-1.54M | ---- | -2,060.87%-497K | ---- | 80.51%-23K | ---- | 35.16%-118K |
| Interest expense - adjustment | ---- | -37.42%811K | ---- | -27.15%1.3M | ---- | 108.31%1.78M | ---- | 46.48%854K | ---- | -11.40%583K |
| Impairment and provisions: | ---- | -19.01%673K | ---- | -76.70%831K | ---- | -47.42%3.57M | ---- | 7,976.19%6.78M | ---- | 139.62%84K |
| -Impairment of trade receivables (reversal) | ---- | -19.01%673K | ---- | -76.70%831K | ---- | -47.42%3.57M | ---- | 7,976.19%6.78M | ---- | 139.62%84K |
| Revaluation surplus: | ---- | -168.19%-9.6M | ---- | 606.27%14.08M | ---- | 160.31%1.99M | ---- | --766K | ---- | ---- |
| -Other fair value changes | ---- | -168.19%-9.6M | ---- | 606.27%14.08M | ---- | 160.31%1.99M | ---- | --766K | ---- | ---- |
| Asset sale loss (gain): | ---- | 35.36%-393K | ---- | 22.15%-608K | ---- | -75.11%-781K | ---- | 66.26%-446K | ---- | -3.93%-1.32M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 35.36%-393K | ---- | 22.15%-608K | ---- | -75.11%-781K | ---- | 66.26%-446K | ---- | -3.93%-1.32M |
| Depreciation and amortization: | ---- | -21.39%11.63M | ---- | -3.07%14.79M | ---- | 10.53%15.26M | ---- | 60.15%13.81M | ---- | 85.54%8.62M |
| Special items | ---- | -50.68%109K | ---- | -86.55%221K | ---- | 41,175.00%1.64M | ---- | ---4K | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -68.18%19.98M | ---- | 2.37%62.79M | ---- | -12.80%61.34M | ---- | 8.41%70.34M | ---- | 22.38%64.88M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 215.84%37.81M | ---- | -1,792.00%-32.64M | ---- | 96.22%-1.73M | ---- | -344.30%-45.64M | ---- | 1,906.44%18.68M |
| Accounts payable increase (decrease) | ---- | -160.71%-32.7M | ---- | 88.79%53.87M | ---- | -17.29%28.54M | ---- | 43.70%34.5M | ---- | 864.62%24.01M |
| Special items for working capital changes | ---- | 186.44%84.69M | ---- | -655.61%-97.97M | ---- | 66.76%-12.97M | ---- | 44.04%-39.01M | ---- | -785.30%-69.7M |
| Cash from business operations | ---- | 886.97%109.78M | ---- | -118.55%-13.95M | ---- | 272.17%75.18M | ---- | -46.66%20.2M | ---- | -37.90%37.87M |
| Other taxs | ---- | -61.62%-5.48M | ---- | 65.67%-3.39M | ---- | -205.57%-9.88M | ---- | 59.65%-3.23M | ---- | 19.46%-8.01M |
| Interest paid - operating | ---- | 31.55%-601K | ---- | -8.40%-878K | ---- | -119.51%-810K | ---- | -5.13%-369K | ---- | -32.95%-351K |
| Special items of business | 2.05%35.32M | ---- | 51.50%34.61M | ---- | -57.48%22.85M | ---- | 457.05%53.73M | ---- | -192.51%-15.05M | ---- |
| Net cash from operations | 2.05%35.32M | 669.22%103.7M | 51.50%34.61M | -128.25%-18.22M | -57.48%22.85M | 288.54%64.49M | 457.05%53.73M | -43.75%16.6M | -192.51%-15.05M | -41.88%29.51M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -46.02%624K | 20.31%1.85M | 142.35%1.16M | 209.05%1.54M | 1,063.41%477K | 2,060.87%497K | 720.00%41K | -80.51%23K | -94.38%5K | -35.16%118K |
| Decrease in deposits (increase) | ---- | 136.92%2.4M | -29.68%2.4M | -94.37%1.01M | 70.99%3.41M | 234.22%17.99M | 118.13%2M | -646.29%-13.41M | -2,008.49%-11.01M | 1,693.51%2.45M |
| Sale of fixed assets | 128.97%332K | -16.69%719K | -82.94%145K | -19.57%863K | 107.32%850K | 9.16%1.07M | -49.26%410K | -45.66%983K | -30.82%808K | 42.22%1.81M |
| Purchase of fixed assets | 99.79%-12K | -210.81%-5.38M | -604.48%-5.66M | 59.79%-1.73M | 76.89%-804K | 11.95%-4.3M | -96.44%-3.48M | 80.76%-4.89M | 63.03%-1.77M | -142.33%-25.39M |
| Purchase of intangible assets | ---- | -399.29%-3.52M | -360.73%-3.52M | -166.04%-705K | -276.35%-764K | 69.78%-265K | ---203K | ---877K | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | -2,916.73%-30.11M | ---- | ---998K | ---471K | ---- |
| Net cash from investment operations | 117.22%944K | -502.25%-3.93M | -272.86%-5.48M | 106.47%977K | 356.84%3.17M | 21.14%-15.11M | 90.07%-1.24M | 8.81%-19.16M | -320.87%-12.44M | -128.92%-21.01M |
| Net cash before financing | 24.50%36.27M | 678.68%99.77M | 11.96%29.13M | -134.91%-17.24M | -50.43%26.02M | 2,027.48%49.38M | 290.96%52.49M | -130.15%-2.56M | -306.53%-27.49M | -79.57%8.5M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | --8M | -16.59%12M | ---- | --14.39M | --6M | ---- |
| Refund | ---- | ---- | ---- | -0.85%-12.29M | -149.47%-20.15M | -539.45%-12.19M | ---8.08M | 85.87%-1.91M | ---- | 42.82%-13.49M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --104M |
| Interest paid - financing | 65.60%-43K | 49.76%-210K | 50.40%-125K | 56.86%-418K | 30.00%-252K | -99.79%-969K | -20.81%-360K | -109.05%-485K | -62.84%-298K | 41.12%-232K |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 72.22%-5M | ---- | ---18M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---18.19M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | -65.28%-6.01M | ---6.01M | ---3.64M | ---- | ---- |
| Net cash from financing operations | 53.83%-1.02M | 78.65%-3.8M | 85.07%-2.21M | -44.35%-17.8M | 12.56%-14.78M | -3,943.93%-12.33M | -499.10%-16.91M | -100.57%-305K | 113.18%4.24M | 367.24%53.11M |
| Net Cash | 30.92%35.25M | 373.84%95.96M | 139.58%26.92M | -194.59%-35.04M | -68.42%11.24M | 1,392.22%37.05M | 253.05%35.59M | -104.65%-2.87M | -23.54%-23.25M | 183.62%61.61M |
| Begining period cash | 87.74%205.33M | -24.27%109.37M | -24.27%109.37M | 34.51%144.41M | 34.51%144.41M | -2.60%107.36M | -2.60%107.36M | 126.70%110.23M | 126.70%110.23M | 80.74%48.63M |
| Cash at the end | 76.52%240.58M | 87.74%205.33M | -12.44%136.29M | -24.27%109.37M | 8.88%155.65M | 34.51%144.41M | 64.35%142.95M | -2.60%107.36M | 191.84%86.98M | 126.70%110.23M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.